U.S. market Closed. Opens in 51 minutes

TCBPW | TC Biopharm (Holdings) Plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/A3.84M1.98M1.98M3.43M
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/A3.84M1.98M1.98M3.43M
Operating Expenses6.91M124.90K13.52M8.32M10.07M
Selling, General & Admin6.87M8.74M3.11M2.21M3.01M
Research & Development7.77M7.59M6.16M6.68M8.61M
Other Operating Expenses6.47MN/AN/AN/AN/A
Operating Income-14.24M-12.08M-7.29M-6.89M-6.64M
Other Expenses / Income7.24M9.05M-7.70M256.89K-253.51K
Before Tax Income-7.00M-3.03M-14.98M-6.63M-6.89M
Income Tax Expenses1.09M1.72M1.41M1.17M826.07K
Net Income-5.91M-1.31M-13.58M-5.46M-6.07M
Interest ExpensesN/AN/AN/AN/AN/A
Basic Shares Outstanding30.89K3.44K1.95K1.89K1.89K
Diluted Shares Outstanding30.89K3.44K1.95K1.89K1.89K
EBITDA-13.61M-11.32M-6.48M-6.01M-5.92M
EBITDA Margin0.00%-294.48%-327.25%-303.65%-172.71%
EBIT-4.82M406.40K-12.17M-4.29M-5.24M
EBIT Margin0.00%10.57%-614.98%-216.61%-152.97%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙